Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells. (Q39865125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Alexandre Puissant

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Arnaud Jacquel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Patrick Auberger

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

P Gamas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

S Grosso

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

P Colosetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

J-M Pasquet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

F-X Mahon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

J-P Cassuto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

2 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

1500-1506

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19340007%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2009.60

25 January 2020

exact match

0 references

cites work

New roles for Src kinases in control of cell survival and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Src family kinases, key regulators of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Increased megakaryocytopoiesis in Lyn-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Janus kinase 2: a critical target in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

PMA-induced phenotypic changes in K562 cells: MAPK-dependent and -independent events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Cleavage and relocation of the tyrosine kinase P59FYN during Fas-mediated apoptosis in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

7 January 2021

Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

7 January 2021

Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

7 January 2021

An absolute requirement for Fyn in T cell receptor-induced caspase activation and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

7 January 2021

The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

7 January 2021

Differential expression of the Kell blood group and CD10 antigens: two related membrane metallopeptidases during differentiation of K562 cells by phorbol ester and hemin

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.60

7 January 2021